CASI Pharmaceuticals Inc
(NASDAQ : CASI)

( )
CASI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.29%80.010.9%$589.41m
CELGCelgene Corporation
-1.22%137.171.1%$556.07m
AMGNAmgen Inc.
0.05%186.281.1%$452.39m
BIIBBiogen Inc.
0.03%344.581.2%$391.35m
REGNRegeneron Pharmaceuticals, Inc.
-0.72%439.372.7%$313.54m
ALNYAlnylam Pharmaceuticals, Inc
-0.97%117.5510.7%$253.20m
VRTXVertex Pharmaceuticals Incorporated
-0.12%154.861.9%$219.44m
INCYIncyte Corporation
-0.43%115.142.5%$206.28m
ALXNAlexion Pharmaceuticals, Inc.
-2.04%140.241.9%$178.91m
ILMNIllumina, Inc.
-0.42%205.623.5%$138.87m
EXELExelixis, Inc.
-2.72%27.536.5%$135.05m
BLUEBluebird Bio, Inc.
-0.79%139.1017.3%$114.78m
BMRNBioMarin Pharmaceutical Inc.
-5.26%88.624.4%$108.97m
CLVSClovis Oncology, Inc.
-3.20%78.7216.5%$108.85m
SRPTSarepta Therapeutics, Inc.
-0.58%51.4216.9%$107.58m

Company Profile

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. The drugs are Captisol-Enabled, ZEVALIN and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.